Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Steris Corp (STE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 7,376,335
  • Shares Outstanding, K 85,020
  • Annual Sales, $ 2,613 M
  • Annual Income, $ 109,970 K
  • 36-Month Beta 1.29
  • Price/Sales 2.82
  • Price/Cash Flow 12.93
  • Price/Book 2.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.61 +2.87%
on 08/28/17
88.11 -1.21%
on 09/11/17
+0.78 (+0.90%)
since 08/22/17
3-Month
80.74 +7.80%
on 07/07/17
88.11 -1.21%
on 09/11/17
+5.15 (+6.29%)
since 06/22/17
52-Week
63.80 +36.43%
on 11/04/16
88.11 -1.21%
on 09/11/17
+13.14 (+17.78%)
since 09/22/16

Most Recent Stories

More News
Earnings Review and Free Research Report: Steris Reported Strong Results with Growth in Net Income and Earnings

Research Desk Line-up: Medtronic Post Earnings Coverage

STE : 87.04 (+0.32%)
MDT : 79.70 (+0.21%)
Global Bakery Products Markets 2016-2024: Growing Preference for Healthy, Organic & All Natural Baked Goods: Reinvigorating Market Growth

The "Bakery Products - Global Strategic Business Report" report has been added to Research and Markets' offering.

NVCR : 21.50 (-0.46%)
STE : 87.04 (+0.32%)
NUVA : 54.25 (-0.66%)
ARAY : 4.50 (+1.12%)
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions

Stryker's (SYK) diverse product portfolio alongside acquisition-driven strategy would continue to boost growth prospects. However, competition in the Chinese market raise concern.

EW : 110.64 (+0.28%)
SYK : 140.89 (+0.16%)
STE : 87.04 (+0.32%)
ALGN : 188.00 (+0.90%)
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

IDEXX Laboratories (IDXX) rides high on strength across all segments, with significant contributions from the Companion Animal Group business. Moreover, a raised guidance buoys optimism.

EW : 110.64 (+0.28%)
LNTH : 17.35 (-0.57%)
STE : 87.04 (+0.32%)
IDXX : 157.50 (+1.12%)
Here's Why Investors Should Buy Align Technology (ALGN) Now

Align Technology (ALGN) continues to ride high on robust growth in the Invisalign space.

EW : 110.64 (+0.28%)
LNTH : 17.35 (-0.57%)
STE : 87.04 (+0.32%)
ALGN : 188.00 (+0.90%)
Haemonetics Plasma Arm Grows Strong, Blood Center Sluggish

Haemonetics (HAE) registers strong top-line growth, banking on Plasma, TEG, hemostasis management as well as a strong cash position. Blood Center drag continues.

EW : 110.64 (+0.28%)
STE : 87.04 (+0.32%)
ALGN : 188.00 (+0.90%)
HAE : 43.03 (+2.40%)
Varian (VAR) Rides on Oncology and Proton Therapy Businesses

Varian Medical's (VAR) oncology and Proton therapy business' growth prospects remain impressive. However, competition in the radiotherapy space raise concern.

EW : 110.64 (+0.28%)
STE : 87.04 (+0.32%)
VAR : 105.19 (+0.54%)
ALGN : 188.00 (+0.90%)
Civitas Solutions (CIVI) Q3 Earnings Beat, Revenues Miss

Civitas Solutions (CIVI) gains on strength in Post-Acute Specialty Rehabilitation Services and Adult Day Health services in Q3. However, tweaked full-year 2017 guidance signals dull prospects.

EW : 110.64 (+0.28%)
STE : 87.04 (+0.32%)
CIVI : 18.90 (-1.31%)
ALGN : 188.00 (+0.90%)
Featured Company News - Intuitive Surgical Splits Stock in Three for One Ratio

Research Desk Line-up: Steris Post Earnings Coverage

STE : 87.04 (+0.32%)
ISRG : 1,031.52 (+0.13%)
Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes

Myriad Genetics (MYGN) rides high on strength in Molecular Diagnostics with significant contributions from GeneSight. Also, hereditary cancer testing continues to witness sequential growth.

EW : 110.64 (+0.28%)
STE : 87.04 (+0.32%)
MYGN : 33.79 (+0.54%)
ALGN : 188.00 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS...

See More

Support & Resistance

2nd Resistance Point 87.61
1st Resistance Point 87.33
Last Price 87.04
1st Support Level 86.73
2nd Support Level 86.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.